Related references
Note: Only part of the references are listed.HLA repertoire of 115 UAE nationals infected with SARS-CoV-2
Halima Alnaqbi et al.
HUMAN IMMUNOLOGY (2022)
Characterizing the diversity of MHC conserved extended haplotypes using families from the United Arab Emirates
Halima Alnaqbi et al.
SCIENTIFIC REPORTS (2022)
Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS)
Fumi Miyagawa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine
Chiraphat Kloypan et al.
PHARMACEUTICALS (2021)
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model
Rika Yuliwulandari et al.
PHARMACOGENOMICS JOURNAL (2021)
HLA-associated adverse drug reactions - scoping review
Chiara Jeiziner et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art
Thawinee Jantararoungtong et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
Applications of Immunopharmacogenomics: Predicting, Preventing, and Understanding Immune-Mediated Adverse Drug Reactions
Jason H. Karnes et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Cross-ethnicity tagging SNPs for HLA alleles associated with adverse drug reaction
Michael Erlichster et al.
PHARMACOGENOMICS JOURNAL (2019)
Association of non-immediate drug hypersensitivity with drug exposure: A case control analysis of spontaneous reports from a Tunisian pharmacovigilance database
Amel Chaabane et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity
Chun-Bing Chen et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Adverse drug reactions
Robin E. Ferner et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Allopurinol-induced Drug Reactions with Eosinophilia and Systemic Symptoms Syndrome with Interstitial Nephritis
T. Aatif et al.
INDIAN JOURNAL OF NEPHROLOGY (2018)
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions
Patricia T. Illing et al.
IMMUNOGENETICS (2017)
Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis
Kuang-Hui Yu et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
HLA-associated drug hypersensitivity and the prediction of adverse drug reactions
Simone Negrini et al.
PHARMACOGENOMICS (2017)
HLA-A*31:01 and carbamazepine-induced DRESS syndrom in a sample of North African population
Kamilia Ksouda et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update
Y. Saito et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2016)
HLA and Delayed Drug-Induced Hypersensitivity
Bernardo Sousa-Pinto et al.
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY (2016)
Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies
Ran Wu et al.
ONCOTARGET (2016)
HLA-DRB and HLA-DQ genetic variability in patients with aspirin-exacerbated respiratory disease
Hossein Esmaeilzadeh et al.
AMERICAN JOURNAL OF RHINOLOGY & ALLERGY (2015)
Pustular drug hypersensitivity syndrome due to allopurinol
Chaker Ben Salem et al.
INDIAN JOURNAL OF PHARMACOLOGY (2015)
PharmGKB summary: very important pharmacogene information for human leukocyte antigen B
Julia M. Barbarino et al.
PHARMACOGENETICS AND GENOMICS (2015)
HLA-allelotype associations with nevirapine-induced hypersensitivity reactions and hepatotoxicity: a systematic review of the literature and meta-analysis
Elena M. Cornejo Castro et al.
PHARMACOGENETICS AND GENOMICS (2015)
HLA Class I and Class II Alleles and Haplotypes Confirm the Berber Origin of the Present Day Tunisian Population
Abdelhafidh Hajjej et al.
PLOS ONE (2015)
Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
Tai-Ming Ko et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Low prevalence of human leukocyte antigen-B*5701 in HIV-1-infected Chinese subjects: a prospective epidemiological investigation
Hongwei Zhang et al.
AIDS RESEARCH AND THERAPY (2015)
Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
Tai-Ming Ko et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The effect of haptens on protein-carrier immunogenicity
Tal Gefen et al.
IMMUNOLOGY (2015)
Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions
Ursula Amstutz et al.
EPILEPSIA (2014)
HLA-B*1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population
Ritu Aggarwal et al.
HUMAN IMMUNOLOGY (2014)
HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis
Sandeep Grover et al.
PHARMACOGENETICS AND GENOMICS (2014)
HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients
Ingrid Fricke-Galindo et al.
PHARMACOGENOMICS (2014)
Clinical Application of Pharmacogenomics: The Example of HLA-Based Drug-Induced Toxicity
Ming Ta Michael Lee et al.
PUBLIC HEALTH GENOMICS (2014)
Predictive markers for carbamazepine and lamotrigine-induced maculopapular exanthema in Han Chinese
Li-Juan Li et al.
EPILEPSY RESEARCH (2013)
HLA-A, -B and-DRB1 allele frequencies in Cyrenaica population (Libya) and genetic relationships with other populations
Andrea Galgani et al.
HUMAN IMMUNOLOGY (2013)
A whole-genome association study of major determinants for allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
M. Tohkin et al.
PHARMACOGENOMICS JOURNAL (2013)
Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China
Xiao-Jing He et al.
PHARMACOLOGICAL REPORTS (2013)
HLA-A, -B, -C,-DRB1 and-DQB1 allele and haplotype frequencies in Saudis using next generation sequencing technique
A. H. Hajeer et al.
TISSUE ANTIGENS (2013)
Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing
M. A. Martin et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
Pharmacogenomics Knowledge for Personalized Medicine
M. Whirl-Carrillo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese
Zhi Hao Cao et al.
PHARMACOGENOMICS (2012)
Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
Yan Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis
A. F. Cristallo et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2011)
Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans
Hye-Ryun Kang et al.
PHARMACOGENETICS AND GENOMICS (2011)
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
Wichittra Tassaneeyakul et al.
EPILEPSIA (2010)
Correlation between genetic HLA class I and II polymorphisms and anthropological aspects in the Chaouya population from Morocco (Arabic speaking)
A. Canossi et al.
TISSUE ANTIGENS (2010)
Should HLA-B*5701 Screening Be Performed in Every Ethnic Group before Starting Abacavir?
Wan Beom Park et al.
CLINICAL INFECTIOUS DISEASES (2009)
Mechanisms of Drug-Induced Allergy
Benno Schnyder et al.
MAYO CLINIC PROCEEDINGS (2009)
The cost-effectiveness of HLA-B*5701 genetic screening to guide initial antiretroviral therapy for HIV
Bruce R. Schackman et al.
AIDS (2008)
High sensitivity of human leukocyte antigen-B*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients
Michael Saag et al.
CLINICAL INFECTIOUS DISEASES (2008)
A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs
Christine Lonjou et al.
PHARMACOGENETICS AND GENOMICS (2008)
Understanding Adverse Drug Reactions and Drug Allergies: Principles, Diagnosis and Treatment Aspects
Zahra Pourpak et al.
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY (2008)
Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in han Chinese
Celeste B. L. Man et al.
EPILEPSIA (2007)
The HLA system: Genetics, immunology, clinical testing, and clinical implications
Sung Yoon Choo
YONSEI MEDICAL JOURNAL (2007)
Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002 - The importance of reporting suspected reactions
DK Wysowski et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
HLA association in aspirin-intolerant asthma: DPB1*0301 as a strong marker in a Korean population
JH Choi et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2004)
HLA class II profile and distribution of HLA-DRB1 and HLA-DQB1 alleles and haplotypes among Lebanese and Bahraini Arabs
WY Almawi et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan
S Farjadian et al.
TISSUE ANTIGENS (2004)
Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity
DA Hughes et al.
PHARMACOGENETICS (2004)
HLA class-I and HLA class-II phenotypic, gene and haplotypic frequencies in Tunisians by using molecular typing data
K Ayed et al.
TISSUE ANTIGENS (2004)
HLA class II allele frequencies in the Lebanese population
H Samaha et al.
MOLECULAR IMMUNOLOGY (2003)
Genetic variations in HLA-B region and hypersensitivity reactions to abacavir
S Hetherington et al.
LANCET (2002)
Adverse drug reactions: definitions, diagnosis, and management
IR Edwards et al.
LANCET (2000)
HLA genes in Arabic-speaking Moroccans: close relatedness to Berbers and Iberians
E Gomez-Casado et al.
TISSUE ANTIGENS (2000)
Share Paper
